Niagen Bioscience (NAGE) Interest & Investment Income (2010 - 2017)
Niagen Bioscience's (NAGE) quarterly Interest & Investment Income came in at $2.0 in Q2 2017, down 99.75% year-on-year from $794.0 in Q2 2016, and up 102.17% on a QoQ basis from -$92.0 in Q4 2016.
Niagen Bioscience (NAGE) Interest & Investment Income (2010 - 2017) Analysis & Trends
Niagen Bioscience (NAGE) has 8 years of Interest & Investment Income data on file, last reported at $2.0 in Q2 2017.
- On a quarterly basis, Interest & Investment Income fell 99.75% year-over-year to $2.0 in Q2 2017; TTM through Apr 2017 was $1269.0, a 60.99% decrease from a year earlier, with the FY2025 full-year figure at $2.1 million, up 88.4% from the prior year.
- Interest & Investment Income for Q2 2017 stood at $2.0, up from -$92.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for NAGE reached as high as $976.0 in Q4 2015 and fell as low as -$92.0 in Q4 2016.
- Historically, Interest & Investment Income has averaged $514.7 across 5 years, with a median of $605.0 in 2015.
- Across the five-year window, Interest & Investment Income surged 324.35% in 2015 and plunged 99.75% in 2017, its largest moves.
- Year by year, Interest & Investment Income stood at $884.0 in 2013, then sank by 73.98% to $230.0 in 2014, then jumped by 324.35% to $976.0 in 2015, then tumbled by 109.43% to -$92.0 in 2016, then jumped by 102.17% to $2.0 in 2017.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $2.0 in Q2 2017, -$92.0 in Q4 2016, and $565.0 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Niagen Bioscience | 258.53 Mn | 191.98 Mn | 19.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 1, 2017 | 2.00 |
| Dec 31, 2016 | -92.00 |
| Oct 1, 2016 | 565.00 |
| Apr 2, 2016 | 794.00 |
| Oct 3, 2015 | 976.00 |
| Jul 4, 2015 | 645.00 |
| Jan 3, 2015 | 838.00 |
| Sep 27, 2014 | 230.00 |
| Jun 28, 2014 | 305.00 |
| Mar 30, 2013 | 884.00 |
| Dec 29, 2012 | 289.00 |
| Sep 29, 2012 | 469.00 |
| Jun 30, 2012 | 1,056.00 |
| Mar 31, 2012 | 1,199.00 |
| Dec 31, 2011 | 238.00 |
| Oct 1, 2011 | 295.00 |
| Jul 2, 2011 | 430.00 |
| Oct 2, 2010 | 578.00 |